Skip to main content
OpenTrials

Clinical trial condition

Relapsing Multiple Scelrosis

Explore clinical trials studying Relapsing Multiple Scelrosis. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Relapsing Multiple Scelrosis trial results

Completed

Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.

NCT02792231

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +9 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Cullman, Alabama, United States
  • Novartis Investigative Site Tucson, Arizona, United States
  • Novartis Investigative Site Aurora, Colorado, United States
View all 178 locations
View Trial Details

Related conditions